Home
About
Overview
Sharing Data
ORCID
Help
History (2)
CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S, Shaughnessy J, Ram S, Rice PA. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol. 2019; 10:321.
View in:
PubMed
subject areas
Animals
Bacterial Vaccines
Complement System Proteins
Epitopes
Gonorrhea
Humans
Lipopolysaccharides
Neisseria gonorrhoeae
Peptides
authors with profiles
Peter A Rice MD
Sanjay Ram MD
Sunita Gulati DSc
Jutamas Shaughnessy MD, PhD